首页 | 本学科首页   官方微博 | 高级检索  
     

奥沙利铂联合氟尿嘧啶和亚叶酸钙治疗铂耐药复发卵巢癌初探
引用本文:王祎晨,徐小仙,孙海燕. 奥沙利铂联合氟尿嘧啶和亚叶酸钙治疗铂耐药复发卵巢癌初探[J]. 临床合理用药杂志, 2012, 0(35): 27-28
作者姓名:王祎晨  徐小仙  孙海燕
作者单位:浙江省肿瘤医院
摘    要:目的探讨奥沙利铂(L-OHP)联合氟尿嘧啶(5-FU)和亚叶酸钙(LV)治疗晚期复发性卵巢癌的临床效果。方法对6例铂耐药复发卵巢癌患者行L-OHP联合5-FU、LV方案化疗,每3周重复,观察其临床效果及毒副反应。结果疗效评定4例部分有效(PR),1例稳定(SD),1例进展(PD),毒副反应均不严重。结论奥沙利铂联合5-FU、LV治疗铂耐药复发卵巢癌有一定疗效,值得进一步研究。

关 键 词:卵巢癌  铂耐药  奥沙利铂  氟尿嘧啶

Study of oxaliplatin plus 5-fluorouracil and leucovorin in the treatment of platinum-resistant recurrent ovarian cancer
WANG Yi-chen,XU Xiao-xian,SUN Hai-yan. Study of oxaliplatin plus 5-fluorouracil and leucovorin in the treatment of platinum-resistant recurrent ovarian cancer[J]. Chinese Journal of Clinical Rational Drug Use, 2012, 0(35): 27-28
Authors:WANG Yi-chen  XU Xiao-xian  SUN Hai-yan
Affiliation:.Department of Gynecological Oncology,Zhejiang Tumor Hospital,Hangzhou,Zhejiang 310022,China
Abstract:Objective To study the clinical efficacy of oxaliplatin plus 5-fluorouracil(5-FU) and leucovorin (LV)in the treatment of platinum-resistant recurrent advanced ovarian cancer patients.Methods 6 patients with platinum-resistant recurrent advanced ovarian cancer were given the chemotherapy of oxaliplatin plus 5-FU and LV every 3 weeks.The clinical effects and adverse reactions were observed.Results 4 patients achieved a partial response (PR),1 patient had stable disease (SD) and 1 patient had progressive disease (PD).The adverse reactions were not serious.Conclusion The chemotherapy of oxaliplatin plus 5-FU and LV shows a certain curative effect in the treatment of patients with platinum-resistant recurrent advanced ovarian cancer,which deserves further research.
Keywords:Ovarian neoplasms  Oxaliplatin  Fluorouracil
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号